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Background: -Conotoxins are small toxins produced by cone snails and antagonists of nicotinic acetylcholine receptors.
Results: Two mutants were created to investigate the unusual C terminus of a novel -conotoxin from Conus longurionis.
Conclusion: We characterized an important residue for discrimination between neuronal and muscle subtype nicotinic ace-
tylcholine receptors.
Significance: This opens perspectives for designing new ligands to affect brain disorders.
-Conotoxins are peptide toxins found in the venom of
marine cone snails and potent antagonists of various subtypes of
nicotinic acetylcholine receptors (nAChRs). nAChRs are cho-
linergic receptors forming ligand-gated ion channels in the
plasma membranes of certain neurons and the neuromuscular
junction. Because nAChRs have an important role in regulating
transmitter release, cell excitability, and neuronal integration,
nAChR dysfunctions have been implicated in a variety of severe
pathologies such as epilepsy, myasthenic syndromes, schizo-
phrenia, Parkinson disease, and Alzheimer disease. To expand
the knowledge concerning cone snail toxins, we examined the
venom ofConus longurionis.We isolated an 18-amino acid pep-
tide named -conotoxin Lo1a, which is active on nAChRs. To
the best of our knowledge, this is the first characterization of a
conotoxin from this species. The peptide was characterized by
electrophysiological screening against several types of cloned
nAChRs expressed inXenopus laevis oocytes. The three-dimen-
sional solution structure of the -conotoxin Lo1a was deter-
mined by NMR spectroscopy. Lo1a, a member of the 4/7 fam-
ily, blocks the response to acetylcholine in oocytes expressing7
nAChRs with an IC50 of 3.24  0.7 M. Furthermore, Lo1a
shows a high selectivity for neuronal versus muscle subtype
nAChRs. Because Lo1a has an unusual C terminus, we designed
two mutants, Lo1a-D and Lo1a-RRR, to investigate the influ-
ence of the C-terminal residue. Lo1a-D has a C-terminal Asp
deletion, whereas in Lo1a-RRR, a triple-Arg tail replaces the
Asp. They blocked the neuronal nAChR 7 with a lower IC50
value, but remarkably, both adopted affinity for themuscle sub-
type 11.
Nicotinic acetylcholine receptors (nAChRs)4 are expressed
in the central and peripheral nervous systems where they are
involved inmany neuronal functions. These neuronal functions
include differentiation and synaptic plasticity, which are the
basis for learning and memory (1–3). The nicotinic acetylcho-
line receptor family is classified into two subtypes based on
their primary sites of expression, namely neuronal and muscle
subtype nAChRs. Both subtypes are pentameric integral mem-
brane protein complexes classified as ligand-gated ion channels
that open in response to binding of the neurotransmitter ace-
tylcholine (ACh) (4, 5). The neuronal subtype nAChRs can
include either exclusively -subunits such as 7, 8, and 9,
called homomeric ion channels or a combination of two or
more different types of subunits, in a heteromeric assembly.
These heteromeric channels are compiled of at least one  sub-
unit (2–10) and one  subunit (2–4). The muscle subtype
nAChRs are composed of four different types of subunits (1,
1, , and /) (6–8).
One of the neuronal nAChRs, 7, has received much atten-
tion since its discovery thanks to the role of 7 in the central
nervous system (CNS) (9). This is because 7 nAChRs are
highly distributed in the brain, including regions involved in
learning and memory, hippocampus, and cerebral cortex (10–
12). Consequently, nAChR dysfunctions have been implicated
in a variety of severe pathologies such as certain types of epi-
lepsy, myasthenic syndromes, schizophrenia, Parkinson dis-
ease, and Alzheimer disease (13–15). Therefore, the discovery
of new ligands binding with high affinity and selectivity to
nAChR subtypes is of prime interest to study these receptors
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and to potentially discover new drugs for the treatment of these
pathologies (16).
New ligands may be found in cone snail species, from which
the so-called family of -conotoxins is a group of potent
nAChRs antagonists (17, 18). These-conotoxins are a series of
structurally and functionally related peptides found in the
venomof cone snail species. They are classified into subfamilies
based on the number of residues in their two “loops” between
conserved Cys residues, with 3/5 (CCX3CX5C), 4/3 (CCX4CX3C),
and4/7 (CCX4CX7C) subfamilies themostcommon(19).The tox-
ins of Conus sp. are usually potent, selective, and small (12–25
amino acids), which is an advantage for cost-effective synthesis
(20). Moreover, they are shown to function as specific probes to
investigate the structure-function relationship of nAChRs (17).
In this study, we report the isolation of a novel 18-amino acid
-conotoxin from the venom of the marine snail Conus longu-
rionis and its electrophysiological screening against six differ-
ent types of nAChRs. To the best of our knowledge, this is the
first conotoxin to be characterized from this species found in
the Indian Ocean near Tamil Nadu, India. The peptide, called
Lo1a, has a W-shaped structural conformation with two loops
that are reinforced by two disulfide bonds. The function of the
peptide revealed that Lo1a was most active against neuronal
homomeric 7 nAChRs. To further determine the structure-
function relationship of Lo1a and its target 7, we engineered
two synthetic analogues, namely Lo1a-D and Lo1a-RRR,
based on the protein sequence of Lo1a and its homology to
other conotoxins from the 4/7 family. The first peptide, Lo1a-
D, has an Asp deletion at the C terminus, whereas in the sec-
ond peptide, an Arg tail replaces this Asp. Both analogues were
found to block the neuronal nAChR 7 with a lower IC50,
but remarkably, they adopted affinity for the muscle subtype
11. These results revealed an unexpected role for the C
terminus in determining subtype selectivity and efficacy. Con-
sequently, our findings might be relevant in the context of
designing novel therapeutic compounds with potential utility
in diseases such asAlzheimer disease, schizophrenia, and atten-
tion deficit hyperactivity disorder because, as previously men-
tioned, 7 nAChRs are thought to play important roles in the
brain (21).
EXPERIMENTAL PROCEDURES
Cone Snail Specimens and Venom Extraction—Specimens of
C. longurionis (identified by Kiener in 1845 and classified by
Tucker andTenorio (22))were collected from the IndianOcean
near Tamil Nadu, India. The venomous apparatuses (venom
bulbs and venom ducts) were extracted from the specimens as
previously described (23). The collected tissue was preserved in
RNAlater solution (Ambion) and stored at20 °C. The venom-
ous apparatuses were used for total RNA extraction and pep-
tide/protein extraction.
Peptide and Purification—Sample fractionation occurred by
reversed phase HPLC (Gilson,Middleton,WI). Two steps were
followed for the separation of the venom compounds. In the
first step, the lyophilized crude venom powder was solubilized
into 50% acetonitrile (ACN)/water, and aliquotswere loaded on
a gel filtration SuperdexTM peptide 10/300 GL column with
50%ACN/water as mobile phase (flow rate, 0.5 ml/min) to sep-
arate the peptides and proteins based on their size. Two sample
collections were made that were stored overnight at 80 °C,
freeze-dried and finally solubilized in 5% ACN/water. For the
second step, an analytical Vydac C18 column (218MS54, 4.6
250 mm, 5-m particle size; Grace, Deerfield, IL) with a two-
solvent system was used: (A) 0.1% TFA/H2O and (B) 0.085%
TFA/ACN. The sample was eluted at a constant flow rate of 1
ml min1 with a 0–80% gradient of solvent B over 90 min (1%
ACN per min after 10 min of solvent A). The HPLC column
fractions were monitored by a UV/VIS-155 detector (Gilson)
scanning both 214 and 280 nm.
Peptide Sequencing—Isolated Lo1a was collected and freeze-
dried for direct peptide sequencing and molecular mass analy-
sis (MALDI-TOF). A Protein Sequencer PPSQ-31A/33A (Shi-
madzu, Japan) was used to determine the amino acid sequence
of the separated compound. In this Edman degradation
method, the sample was loaded onto a polybrene-pretreated,
precycled glass fiber disk and Edman sequenced for 24 residue
cycles.
Peptide Synthesis and Folding—Lo1a was synthesized using
Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry by Gene-
Cust (Luxemburg). Lo1a-D and Lo1a-RRR were synthesized
by GenicBio Limited (Shanghai, China). Formation of the two
disulfide bridges was carried out by adopting the selective pro-
tection anddeprotection strategy in vitro. The resulting bicyclic
peptides were subsequently purified by HPLC and analyzed
with ESI-MS, then freeze-dried, and stored at20 °C until use.
Functional Characterization—Complementary DNA encoding
the nAChR channels was subcloned into the corresponding vec-
tor: human 3/pcDNA3(XbaI), human 4/pGEM-HE(NheI),
chick 7/pBlueScript(NotI), human 2/pSP64(PvuII), human
4/pcDNA3(XbaI), rat 1/pSP0oD(SalI), rat 1/pSP0oD(SalI), rat
/pSP0oD(SalI), rat /pSP0oD(SalI), and rat /pSP0oD(SalI). The
linearized plasmids (respective restriction enzymes are indicated
in parentheses) were transcribed using theT7 (3,4,7, or4) or
theSP6(2,1,1,,, or)mMESSAGEmMACHINEtranscrip-
tion kit (Ambion, Austin, TX).
The harvesting of stage V–VI oocytes from anesthetized
female Xenopus laevis frogs was previously described (24).
Oocytes were injected with 50–70 nl of cRNA at a concentra-
tion of 1–3 ng/nl using amicro-injector (Drummond Scientific,
Broomall, PA). The oocyteswere incubated in aND-96 solution
containing: 96mMNaCl, 2mMKCl, 1.8mMCaCl2, 2mMMgCl2,
and 5 mM HEPES (pH 7.4), supplemented with 1.25 ml/liter
gentamicin and 90 mg/liter theophylline. The oocytes were
stored for 1–5 days at 16 °C until sufficient expression of
nAChRs was achieved.
Whole cell currents from oocytes were recorded at room
temperature (18–22 °C) by the two-electrode voltage clamp
technique using a GeneClamp 500 amplifier (Molecular
Devices, Sunnyvale, CA) controlled by a pClamp data acquisi-
tion system (Molecular Devices). The oocytes were placed in a
bath containing ND-96 solution. Voltage and current elec-
trodes were filled with 3 M KCl, and the resistances of both
electrodes were between 0.5 and 1.5 M. The elicited currents
were sampled at 100 Hz and filtered at 50 Hz using a four-pole,
low pass Bessel filter. To eliminate the effect of the voltage drop
across the bath grounding electrode, the bath potential was
Structure-Function Elucidation of a New-Conotoxin
9574 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 14•APRIL 4, 2014
 at B
IO
M
ED
ISCH
E BIBLIO
TH
EEK
 on July 1, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
actively controlled by a two-electrode bath clamp. During
recordings, oocytes were continuously perfused with ND96-A
(ND96 with 1 M atropine; except for 7) at a rate of 2 ml/min,
with the conopeptides applied for 30 s before ACh was added.
ACh (200 M for 7, 70 M for 34, 50 M for 42 and 44,
and 10 M for 11 and 11) was applied for 2 s at 2
ml/min, with 30-s washout periods between different ACh
applications and 200 s after toxin application. The percentage
response or percentage inhibition was obtained by averaging
the peak amplitude of three control responses (two directly
before exposure to the peptide and one after 200 s of washout).
Whole cell current traces were evoked from a holding poten-
tial of 90 mV. Concentration-response curves were con-
structed by application of different toxin concentrations to the
nAChR-expressing oocytes. The percentage of nAChR block-
ade was plotted against the logarithm of the applied concentra-
tions and fitted with the Hill equation: y  100/[1  (IC50/
[toxin])h], where y is the amplitude of the toxin-induced effect,
IC50 is the toxin concentration at half-maximal efficacy, [toxin]
is the toxin concentration, and h is the Hill coefficient.
Comparison of two sample means was made using a paired
Student’s t test (p 0.05). All data are presented as themeans	
S.E. of at least three independent experiments (n 3). All data
were analyzed using pClampClampfit 10.0 (MolecularDevices)
and Origin 7.5 software (Originlab, Northampton, MA).
NMR Spectroscopy—NMR spectra were recorded with a 2.6
mM solution (200 l, pH 5.9) of the folded conopeptide in D2O
and in H2O:D2O (9:1) mixture at 5 °C on a 600 MHz Bruker
Avance II spectrometer equipped with a 5-mm TCI HCN Z
gradient cryoprobe. Spectra were processed using Topspin 2.1
(Bruker Biospin) and analyzed by using CARA program (ver-
sion 1.8.4) (25).
In the one-dimensional and two-dimensional spectra that
were recorded in H2O:D2O mixture, the water signal was sup-
pressed by using excitation sculpting with gradients (26). The
two-dimensional NOESY in H2O (mixing time, 150 and 300
ms)was recordedwith a sweepwidth of 7210Hz in both dimen-
sions, 64 scans, 2048 data points in t2, and 1024 free induction
decays in t1.
A two-dimensional total correlation spectroscopy (TOCSY)
(27) in 90%H2Owas recordedwithDIPSI2 sequence formixing
(mixing time, 80 ms). A double quantum-filtered COSY (28) in
H2Owas acquired using excitation sculpting with gradients for
water suppression with a sweep width of 7210 Hz in both
dimensions, 64 scans, 2048 data points in t2, and 1024 free
induction decays in t1. In the processing of two-dimensional
spectra, the data were apodized with a shifted sine bell square
function in both dimensions. Proton chemical shifts were cali-
brated by using residual HOD (water in which one of the pro-
tons has been exchanged with a deuteron) signal as reference
(4.9745 ppm at 5 °C).
Natural abundance 1H,13C heteronuclear single quantum
correlation (1H-13C HSQC) spectrum in D2O was recorded
with sensitivity enhancement and gradient coherence selection
optimized for selection of aliphatic CH groups (JCH 135 Hz)
using 64 scans, 1024/2048 complex data points, and 12,072/
7210 Hz spectral widths in t1 and t2, respectively. For the selec-
tion of aromatic CH groups, 170Hzwas used for JCH alongwith
32 scans and 64/2048 complex data points. The two-dimen-
sional HSQC-TOCSY spectrumwas recorded with a pulse pro-
gram consisted of an HSQC building block followed by a clean
MLEV-17 TOCSY transfer step of 80 ms of mixing time just
prior to the refocusing gradients with exactly the same spectral
widths and number of points as in the aliphatic 1H-13C HSQC.
Distance restraints were derived from cross-peak volumes of
the NOESY spectrum recorded with 150 ms of mixing time.
Estimated interprotondistanceswere derived using the isolated
spin pair approximation, rij  rref (vref/vij)1/6, where rij is the
estimated interproton distance, rref is the fixed internal refer-
ence distance, and vref and vij are the NOE cross-peak volumes
of the reference and estimated cross-peaks, respectively. Aver-
age cross-peak volume of the geminal methylene proton pairs
was used as reference volume, which corresponds to the fixed
reference distance of 1.8 Å. Generally an experimental error
of 	 20% on the calculated interproton distances was used as
upper and lower bounds. The 3JHNH coupling constants were
measured from the one-dimensional proton spectrum
recorded in H2O and then converted to dihedral restraints as
follows: 3JHNH
 8 Hz, 	120	 30°; 3JHNH 6 Hz; 	
60	 30°;
 180	 30° to define the trans X-Pro7/14 confor-
mation as confirmed by the observation of strong NOE inter-
actions between H(n) and HD2, HD3 (n1) Pro.
All structure calculations were performed by using Xplor-
NIH program, version 2.25 (29). A set of 100 structures was
generated by torsion angle molecular dynamics, starting from
an extended strand and by usingNMR-derived restraints. After
the torsion angle molecular dynamics round (30), the majority
of the structures had converged to very similar structures with
similar total energies and having no violations of the NOE and
dihedral restraints. The 15 lowest energy structures were used
for further refinement during a “gentle molecular dynamics”
round in explicit water (31). A box ofwaterwas constructed and
optimized around selected structures obtained from the previ-
ous torsion angle dynamics step. The final stage of refinement
commenced with a 20-ps constant temperature molecular
dynamics simulation at 300 K (20,000 steps of 0.001 ps) andwas
followed by a 200-step conjugate gradient energyminimization
of the average structure of the last 10 ps of the 20-ps simulation.
Structures were analyzed by using PROCHECK (32). Visual
representations of the molecule were created by using the Uni-
versity of California, San Francisco Chimera program (version
1.8rc).
RESULTS
Isolation of a Novel -Conotoxin from C. longurionis Venom—
N-terminal Edman degradation of the purified active peptide
revealed a novel 18-residue -conotoxin, called Lo1a, with the
sequence H-EGCCSNPACRTNHPEVCD-NH2 (bridges Cys3–
Cys9 and Cys4–Cys17) and a molecular mass of 1930.12 Da,
determined by MALDI-TOF (4800 Analyzer; Applied Biosys-
tems). To the best of our knowledge, Lo1a is the first conotoxin
isolated and pharmacologically characterized fromC. longurio-
nis, a species of a (vermivorous) cone snail commonly found in
the Indian Ocean in Tamil Nadu, India. It has highest sequence
homology with Qc1.5 (81%; Fig. 1), which is isolated from
Conus quercinus, another vermivorous cone snail (33).
Structure-Function Elucidation of a New-Conotoxin
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-Conotoxin Lo1a Analogues—Typically, -conotoxins end
C-terminally with a Cys (Fig. 1). Interestingly, Lo1a ends with
anAsp following this Cys. Only twomore conotoxins having an
Asp at the C terminus are described, namely Lp1.4 (34) and
Bt1.91 (35). To explore the influence of the C-terminal Asp18 to
the functional properties of Lo1a, we created two synthetic ana-
logues: Lo1a-D and Lo1a-RRR. The synthetic analogue
Lo1a-D (molecular mass, 1815.03 Da) is C-terminally trun-
cated, whereas in Lo1a-RRR (molecular mass, 2283.60 Da), the
negatively charged Asp is replaced by a positively charged Arg
tail.
Lo1a Inhibition of Recombinant nAChR Subtypes—The
potency and selectivity of Lo1a at neuronal nAChRs was deter-
mined by examining its effect on ACh-evoked currents medi-
ated by different nAChR subunit combinations expressed in
Xenopus oocytes. Lo1a (10 M) inhibited ACh-evoked current
amplitude mediated by 7 (85%), 34 (40%), 42 (19%), and
44 (13%) (Fig. 2). No remarkable effect was seen at themuscle
subtype nAChRs 11 and 11 (for concentrations up to
50 M). Concentration-response curves for Lo1a inhibition of
ACh-evoked currents at the7 nAChR revealed an IC50 value of
3.24	 0.70 M (Fig. 3).
Influence of C-terminal Truncation and Replacement of D by
RRR—We synthesized a C-terminally truncated and a triple
Arg-tailed analogue of Lo1a to examine its activity at different
nAChR subtypes (Figs. 4 and 5). Interestingly, Lo1a-D was
more potent at the neuronal nAChR7 (IC50 0.80	 0.01 nM)
but surprisingly also adopted affinity for the muscle subtype
11 (IC50 4.40	 0.18 M) (Fig. 6). The same was noticed
for Lo1a-RRR, where the IC50 for 7 was 1.06 M, and an IC50
value of 1.47	 0.39 M was determined for 11 (Fig. 6). An
overview of subtype selectivity for Lo1a and both mutants is
given in Fig. 7.
NMR Spectroscopy—NMR spectral analysis shows the for-
mation of a single set of resonances for the conopeptide, indi-
cating that it adopts one type of structural form in solution.
Resonance assignment was performed by following standard
procedures as outlined by Wüthrich (36). Complete sequence
specific proton assignments were achieved by analyzing homo-
nuclear two-dimensional spectra (double quantum-filtered
COSY, TOCSY, and NOESY). Initially the NH and H reso-
nances of the individual spin systems (except Pro) were identi-
fied by analyzing the “fingerprint” region of the double quan-
tum-filtered COSY and TOCSY spectra, and the remaining
resonances of the spin systems were identified by following the
“TOCSY tower.” Sequence specific assignments were achieved
by linking individual spin system via sequential inter-residue
Hn-HN(n1) cross-peaks in the fingerprint region of the
NOESY spectrum.Carbon assignmentswere also performed by
using 1H-13C HSQC spectra, which further reconfirmed most
of the homonuclear proton assignments and clarified the H
and H proton assignments of the two proline residues that
were not resolved in the homonuclear two-dimensional spectra
because of signal overlaps. The geminal methylene protons
were not assigned stereo-specifically, and the NOE distance
restraints involving these protons were used ambiguously dur-
ing structure calculation in the Xplor-NIH program. Fig. 8
shows the observed short and medium range NOEs that were
used for the resonance assignment, 3JHNH, and chemical shift
index along the amino acid sequences of -conotoxin Lo1a.
The chemical shift index values indicate the presence of a-he-
lix in the middle of the peptide from residue Pro7 to Asn12.
Fig. 9 displays the structural representations of the final
ensemble of 15 superimposed structures (Fig. 9A) and the min-
imum energy closest to average structure (Fig. 9B) of -cono-
toxin Lo1a. The peptide structures are well defined with back-
bone and heavy atom root mean square deviations of 0.43 and
FIGURE 1.Alignment of 414/7 conotoxinswith Lo1a, sortedbypercent-
age of identity (indicated in the left column) with Lo1a. References from
top to bottom are as follows: EI (C. ermineus (63)), AuIC (C. aulicus (72)), AuIA
(C. aulicus (72)), MrIC (C. marmoreus (73)), Lp1.1 (C. leopardus (74)), PnIB
(C. pennaceus (75)), Lp1.7 (C. leopardus (35)), Lp1.8 (C. leopardus (35)),
Mr1.2 (C. marmoreus (35)), Lp1.9 (C. leopardus (35)), Qc1.4b (C. quercinus (35)),
PIA (C. purpurascens (62)), PnIA (C. pennaceus (75)), AnIB (C. anemone (49)),
Qc1.6 (C. quercinus (35)), GIC (C. geographus (76)), TxIA (C. textile (45)), MII
(C. magus (55)), EpI (C. episcopates (77)), Qc1.4a (C. quercinus (35)), Lp1.10
(C. leopardus (35)), Vc1.1 (C. victoriae (53)), TxIB (C. textile (35)), RegIIA (C. regius
(52), OmIA (C. omaria (50)), Mr1.1 (C. marmoreus (34)), Mr1.3 (C. marmoreus
(35)), LvIA (C. lividus (35)), LsIA (C. limpusi (53)), Lp1.4 (C. leopardus (34)), Bt1.91
(C. betulinus (35)), Lp1.3 (C. leopardus (35)), Sa1.6 (C. sanguinolentus (35)),
PuSG1.1 (C. pulicarius (35)), Sa1.9 (C. sanguinolentus (35)), PeIA (C. pergrandis
(18)), Bt1.2 (C. betulinus (35)), GID (C. geographus (51)), ArIA (C. arenatus (61)),
ArIB (C. arenatus (61)), Qc1.5 (C. quercinus (35)), and Lo1a (C. longurionis, this
work).
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0.83, respectively, over residues 3–17. The structural evaluation
using PROCHECK demonstrates that all the resulted struc-
tures have no bad nonbonded contacts, and all the backbone
dihedral angles are within the allowed regions of the Ram-
achandran plot (63% residues fall in the most favored region).
Detailed structure determination statistics are provided in
Table 1. The coordinates for 15 structures, NMR restraints, and
chemical shifts have been deposited in the RCSB Protein Data
Bank with RCSB identifier RCSB103496 and Protein Data Bank
code 2MD6.
A close look into the structure (Fig. 9) of the -conotoxin
Lo1a reveals that the peptide backbone adopts a compact
W-shaped conformation having two loops that are reinforced
by two disulfide bonds (Cys3–Cys9 and Cys4–Cys17). Residues
from Pro7 to Asn12 at the bottom of the W shape formed a
-helix involving two turns. In addition to this, in the N-termi-
nal part of the peptide structure, two overlapping -turns (type
IV) exist between Gly2 and Ser5 and between Cys4 and Pro7. In
the C-terminal part of the peptide, residues fromPro14 to Cys17
formed a type I/IV  -turn. This type of overall W-shaped
molecular topology/fold was previously identified in the
reported structures of other 4/7 subfamily -conotoxins (37,
38).
DISCUSSION
-Conotoxins are a family of cysteine-rich peptides that
behave pharmacologically as competitive antagonists of the
nicotinic acetylcholine receptor (39). In general, there are two
main nAChR subtypes, the neuronal and muscle subtype
nAChRs. Considering the neuronal subtype nAChRs, and par-
ticularly their ACh-binding site, a high percentage of sequence
identity exists among the knownneuronal nAChR subunits (40,
41). Because of the high sequence conservation, it has been
difficult to obtain subtype selective ligands, principally agonists
that take action deep within the conserved ACh-binding
pocket. However, recently, selective peptide antagonists from
cone snail venom have shown to be highly selective pharmaco-
logical tools displaying the ability to discriminate among many
of the different nAChR subunit combinations (41). This high
selectivity toward a particular mammalian nAChR subtype is
often established through specific interactions with particular
residues located outside the conserved ACh-binding site (42).
FIGURE 2. Electrophysiological profile of Lo1a. During recordings, oocytes were continuously perfused with ND96-A (ND96 with 1 M atropine; except for
oocytes expressing7 nAChR) at a rate of 2ml/min, with 10M Lo1a applied for 30 s before AChwas added. ACh (200M for7, 70M for34, 50M for42
and44, and10M for11 and11)was applied for 2 s at 2ml/min,with 30-swashoutperiodsbetweendifferentAChapplications and200 s after toxin
application.
FIGURE 3. Concentration-response curve on 7 nAChR. Different concen-
tration of Lo1a (), Lo1a-D (E), and Lo1a-RRR (‚) were tested on 7. The
corresponding IC50 values are: 3.24	 0.70, 0.80	 0.01, and 1.06	 0.00 M,
respectively. Currents were obtained as described under “Experimental Pro-
cedures.” The percentage of block was plotted against the logarithm of the
tested concentrations. The results were fit with the Hill equation.
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Nowadays, co-crystal structures of-conotoxins binding to the
ACh-binding protein (43), which is a protein model for the
extracellular ligand-binding domain of nAChRs, can offer use-
ful information about the molecular interactions of these small
peptides (44, 45).
Lo1a Has a Typical -Conotoxin Structure—In our study, we
revealed the amino acid composition and the three-dimen-
sional structure of a new 4/7-conotoxin from C. longurionis,
called Lo1a. The peptide was investigated electrophysiologi-
cally, and it was found that Lo1a inhibits 7 nAChRs preferen-
tially. Once the activity of Lo1a had been determined, we
employed NMR-based techniques to elucidate the structure of
this novel peptide. According to Marx et al. (46), NMR is the
method of choice for determining conotoxin structures,
FIGURE 4. Electrophysiological profile of Lo1a-D.During recordings, oocytes were continuously perfused with ND96-A (ND96 with 1M atropine; except
for oocytes expressing 7 nAChR) at a rate of 2ml/min, with 10M Lo1a-D applied for 30 s before AChwas added. ACh (200M for 7, 70M for 34, 50M
for42 and44, and 10M for11 and11) was applied for 2 s at 2ml/min, with 30-s washout periods between different ACh applications and 200 s
after toxin application.
FIGURE 5. Electrophysiological profile of Lo1a-RRR.During recordings, oocytes were continuously perfusedwith ND96-A (ND96with 1M atropine; except
for oocytes expressing7 nAChR) at a rate of 2ml/min, with 10M Lo1a-RRR applied for 30 s before AChwas added. ACh (200M for7, 70M for34, 50M
for42 and44, and 10M for11 and11) was applied for 2 s at 2ml/min, with 30-s washout periods between different ACh applications and 200 s
after toxin application.
Structure-Function Elucidation of a New-Conotoxin
9578 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 14•APRIL 4, 2014
 at B
IO
M
ED
ISCH
E BIBLIO
TH
EEK
 on July 1, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
because conotoxins are generally difficult to crystallize and are
not amenable to x-ray methods, with a few exceptions such as
PnIA and PnIB (47, 48). -Conotoxin Lo1a was shown to be
highly soluble, andNMRspectrawere readily assigned andused
to generate a high resolution structure. This structure demon-
strated that Lo1a sharesmany of the structural and biochemical
properties that define -conotoxins, including the characteris-
tic I–III, II–IV disulfide connectivity and the size of the first and
the second loop of the peptide, i.e. four and seven residues,
respectively. Several -conotoxins including AnIB (49), OmIA
(50), GID (51), RegIIA (52), and LsIA (5) have an SXPA motif
similar to the first loop of Lo1a. The peptide also shares the
common fold comprising a short disulfide bond stabilized helix
and a conserved proline. This proline is shown to be the only
highly conserved amino acid residue apart from the cysteines
and is responsible for helix initiation by inducing the 310 helix
turn in the peptide backbone (39). Dutertre and Lewis (39)
revealed that this small -helix structure appears to be a very
important determinant for binding, even if the orientations and
specific interactions differ significantly. Because the side chains
in an -helix protrude at 360°, this structure is likely suitable to
allow multiple contacts on both sides of a binding pocket
located at the interface of two subunits (39).
As indicated in the previous section, Lo1a was shown to be
very selective for the neuronal versus the muscle nicotinic
receptors. Other -conotoxins having these characteristics are
ImI, 4/3 conotoxin from Conus imperialis (54) and MII, 4/7
conotoxin from Conus magus (55). ImI targets 7 and 9 sub-
units with an IC50 of 220 nM and 1.8 M, respectively (56). Its
amino acid sequence, GCCSDPRCAWRC, shares three non-
Cys amino acid residues with the sequence of Lo1a. These sim-
ilar residues are Gly at theN terminus, Ser after the secondCys,
and Pro between the second and the third Cys. The latter was
identified as one of the determinants, in addition to Asp5, Arg7,
and Trp10 to influence the potency of ImI at the 7 nAChR (57,
58). -Conotoxin MII blocks 6-containing nAChRs and 32
with an IC50 of 0.39 nM (6/323) and 2.18 nM, respectively
(59). If its amino acid sequence, GCCSNPVCHLEHSNLC, is
aligned with Lo1a, 5 of 14 non-Cys residues of Lo1a are similar
with MII, resulting in a homology percentage of 56 (Fig. 1).
Everhart et al. (60) identified amino acid residues Asn5, Pro6,
and His12 from MII as major determinants for potency on the
32 nAChR. Consequently, it is expected that Lo1a also tar-
gets 32 nAChRs.
Lo1a Has an Atypical C Terminus—The N-terminal amino
acid residue of -conotoxins is typically a glycine followed by
the first two cysteine residues (Fig. 1).However, sequence align-
ment of Lo1a with other -conotoxins reveals, in addition to a
FIGURE 6.Concentration-response curveon11nAChR.Different con-
centrations of Lo1a (), Lo1a-D (E), and Lo1a-RRR (‚) were tested on
11. The corresponding IC50 values for Lo1a-D and Lo1a-RRR are: 4.40	
0.18 and 1.47 	 0.39 M, respectively. Currents were obtained as described
under “Experimental Procedures.” The percentage of block was plotted
against the logarithm of the tested concentrations. The results were fit with
the Hill equation.
FIGURE 7.Overview of subtype selectivity. The three peptides, Lo1a, Lo1a-
D, and Lo1a-RRR were tested on six different nAChRs: 11, 11, 7,
42,34, and44 at a concentration of 10M. The data are represented as
themeans	 S.E. (indicated by error bars); each experimentwas performed at
least three times (n 3).
FIGURE 8. Sequence and disulfide connectivity of -conotoxin Lo1a
along with a summary of short and medium range NOEs, 3JHNH (
3JN)
couplings, and chemical shift index for the H protons. The thickness of
each bar represents relative strength of NOEs (strong, medium, and weak).
Filled circle, 3JHNH6Hz; shaded circle,
3JHNH6–8Hz;open circle,
3JHNH

8Hz. The filled rectanglesaboveandbelow thehorizontal line represent chem-
ical shift indexvaluesof1and1, respectively.Note thepresenceof-helix
from Pro7 to Asn12, which is common to all 4/7 subfamily conotoxins.
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unique loop 2 sequence, an atypical terminal amino acid
sequence, because both N and C termini contain negatively
charged amino acid residues, i.e. glutamic acid and aspartic
acid, respectively. Few conotoxins have other residues preced-
ing the first cysteine. From these conotoxins, ArIA (61), ArIB
(61), GID (51), PIA (62), EI (63), and LsIA (5) are the most
investigated (Fig. 1). On the other hand, a negative residue at
the C terminus of an -conotoxin has only been observed in
conotoxins Lp1.4 from Conus leopardus (33) and Bt1.91 from
Conus betulinus (35). However, to the best of our knowledge,
the influence of this negative C-terminal residue has never been
investigated before.
C-terminalChargesAre Important forNeuronal/Muscle Sub-
type Selectivity and Efficacy—To explore the role of the C-ter-
minal Asp of Lo1a, two analogues were synthesized: one C-ter-
minally truncated peptide named Lo1a-D and another named
Lo1a-RRRwith an extremely positively chargedArg tail at theC
terminus. Deleting the C-terminal amino acid resulted in a
more positively charged peptide, whereas the rationale for the
Arg tailing peptide can be found in the sequences of ArIA and
ArIB from Conus arenatus (Fig. 1). Both peptides, ArIA and
ArIB, are potent inhibitors of the 7 nAChR having IC50 values
in the nanomolar range (61).Whiteaker et al. (61)made a series
of directed substitutions in ArIB to obtain a more selective 7
antagonist. The mutant ArIB[V11L,V16D] improved its selec-
tivity on 7 more than 10,000-fold, suggesting the importance
of Lys and Asp at positions 11 and 16, respectively. Via replac-
ing the C-terminal Asp by a triple Arg tail, we aimed to inves-
tigate whether we could improve potency/selectivity on7 with
Lo1a-RRR.
The two synthetic C-terminally modified analogues revealed
unexpected roles for the C terminus in determining subtype
selectivity and efficacy. Both mutants demonstrated more
potency toward the neuronal 7 AChR because both IC50 val-
ues decreased from 3.24 M (Lo1a) to 0.80 M (Lo1a-D) and
1.06M (Lo1a-RRR). Because the difference in potency was not
very astonishing, we can conclude that the C-terminal resi-
due(s) does not play a crucial role in activity on7. Remarkably,
both mutants conferred affinity for the adult muscle subtype
nAChR 11 (IC50 values 4.40 	 0.18 M (Lo1a-D) and
1.47	 0.39 M (Lo1a-RRR)) but much less for the fetal muscle
subtype nAChR 11. Consequently, C-terminal charges
seem to have an influence in making the distinction between
neuronal or muscle subtype nAChRs and even among muscle
subtype nAChRs.
-Conotoxins that target selectivelymuscle subtype nAChRs
typically have a 3/5 structure (64). An exception is the -cono-
toxin EI (4/7) fromConus ermineus that selectively targets the
/ interface of muscle subtype nAChRs (63). Conotoxins that
distinguish between the adult and the fetal muscle subtype
nAChRs are rare. One example is -conotoxin PrIIIE from
Conus parius, characterized by Lluisma et al. (65), which
showed higher inhibition potency against the adult subtype
(IC50 of 245nM) than the fetal subtype nAChR (IC50 of 3.24M).
FIGURE 9.NMR solution structure of -conotoxin Lo1a. A, stereo views of a family of 15 final structures of -conotoxin Lo1a with superimposed backbone
heavy atoms (N, CA, C). Disulfide bonds are shown in yellow as pseudobonds. B, front andback ribbon views of the closest to average structure of-conotoxin
Lo1a. Side chain heavy atoms are displayed along with residue label. The two views are related by a 180° rotation around the vertical axis.
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Another-conotoxin PIIIE fromConus purpurascens shows an
IC50 of 7.4Mon the adultmuscle subtype, but no inhibition on
the fetal muscle subtype for concentrations up to 10M. Teich-
ert et al. (66) reportsA-conotoxinOIVB fromConus obscurus,
a unique selective inhibitor of the mammalian fetal muscle
nAChR (IC50 of 56 nM), whereas affinity for the adult muscle
nAChR is more than 1800-fold lower. According to Groebe et
al. (67), many of the -conotoxins bind with 10,000-fold higher
affinity to the mammalian / interface than the / interface.
The peptides Lo1a-D and Lo1a-RRR, which are described in
this work, apparently demonstrate higher affinity to the /
interface.
Considering the terminal charges of Lo1a and its analogues,
it can be expected that the positively charged triple-Arg tail in
Lo1a-RRR is more likely to adopt a conformation extended
away from the negatively charged N terminus (as derived by
torsion-angle molecular dynamics and energy minimization in
the structural model). In contrast, the structure from Lo1a has
a more “compact” conformation, with an inward-facing C ter-
minus as derived from the solution state NMR structural data.
Consequently, because the C and N terminus of Lo1a are in
close proximity (less than 10 nm), the charges at both termini
may interact, playing a role in making the distinction between
neuronal versus muscle subtype nAChRs. Further structure-
function studies combined with co-crystallization experiments
are necessary to see whether this hypothesis is applicable for
Lo1a-D.
Muscle and Neuronal Subtype nAChR Binding Sites: Structural
Receptor Elements for Binding of Lo1a and Its Homologous—
The muscle subtype nAChR has a pentameric structure com-
prised of two 1 subunits, one 1, one , and, depending on
whether the receptor is in an embryonic or adult stage, one  or
 subunit, respectively. Each 1 subunit folds such that the pri-
mary binding site directly faces a neighboring subunit, which is
either a / or a  subunit. The  subunit is believed to be the
one that forms stable contacts being the lone subunit between
the two 1 subunits, whereas the  subunit pairs with the 
subunit to form stable contacts between the 1 subunits on the
opposite side. Because two 1 subunits are separated by at least
one non 1 subunit, correct coupling between these subunits is
required for cooperative binding of agonists (68). Agonists of
themuscle subtype nAChR initiate channel opening and desen-
sitization by binding to a site on each of these two 1 subunits
(69). Moreover, Arias and Blanton (19) established that two
adjacent cysteines (at positions 192 and 193 according to the
sequence number of Torpedo AChR) in the 1 subunits are
involved in the recognition and binding of cholinergic agonists
and competitive antagonists. Later on, Sine (70) demonstrated
that not only do the two 1 subunits form the binding sites of
agonists and antagonists, but the /() and  subunits are also
involved. Agonists and antagonists can specifically distinguish
between the 1/(1) and 1 binding sites of the fetal/(adult)
muscle acetylcholine receptor because of different contribu-
tions by the/() and  subunitswhere aminimumof four loops
in both subunits is required to create the agonist binding site
(71). In 1991, Sine andClaudio (68) showed that AChRs lacking
either a  or a  subunit assemble into pentamers with subunit
compositions, ()2()2 and ()2()2. Therefore, we tried to
express ()2()2 and ()2()2 and ()2()2 heterologously to
determine which binding site is responsible for interactions
causing the observed results. Unfortunately, because of poor
heterologous expression in frog oocytes, these experiments
could not provide sufficient information about the binding sites
of Lo1a-D and Lo1a-RRR.
Whereas the two ligand-binding sites of muscle AChRs are
formed at interfaces between 1 and , , or  subunits, binding
sites of 7 neuronal AChRs are formed at interfaces between
identical 7 subunits. Residues of the  face of the binding site,
termed the () face, cluster in three well separated regions of
the primary sequence, termed loops A, B, and C (71). The sta-
bilization of this loop C conformation in an open state appears
to be an essential element for antagonist activity. The stabiliza-
tion in the ACh-binding protein is established on the basis of
the loop C vicinal disulfide bonds where the -conotoxin disul-
fide bond Cys I–III interacts, as is shown for conotoxins PnIA
and ImI (39). This type of antagonist activity can also be
expected for Lo1a and its analogues, because both conotoxins,
PnIA and ImI, are structurally quite homologous to Lo1a. In
summary, our study provides insight into-conotoxin pharma-
cology and the molecular basis of nAChR selectivity, highlight-
ing the influence and importance of C-terminal residues on
conotoxin pharmacology.
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